TP53 and pulmonary arterial hypertension: In the hypoxia-treated mice and monocrotaline-induced PAH rats, p53 expression is reduced in the aging PASMCs and may contribute to pulmonary vascular remodeling by promoting PASMC proliferation and calcium influx 100.